fda decision about compound tirzepatide ban on compounded tirzepatide: Switch to name brand medications Is Tirzepatide FDA Approved? Approval

Each opened multi-dose vial requires clear labeling with use dates

Economic value of nonsurgical weight loss in adults with obesity

Glutathione deficiency correlates with chronic disease and can be replenished from exogenous sources, such as natural glutathione in food and glutathione supplements

If monotherapy proves insufficient, clinicians may consider: Optimising the current medication (ensuring proper technique for Saxenda injections, addressing side effects, reinforcing dietary adherence) Switching to an alternative medication rather than adding a second Intensifying lifestyle support through referral to specialist weight management services Evaluating for bariatric surgery in patients meeting criteria (typically BMI 40 kg/m or 35 kg/m with comorbidities, with consideration for people with recent-onset type 2 diabetes at BMI 30-34.9) Combination pharmacotherapy is not standard practice and would typically only be considered by specialists in weight management services after careful evaluation